Last updated on March 2018

A Safety and Efficacy Study of JNJ-42165279 in Participants With Social Anxiety Disorder


Brief description of study

The purpose of this study is to investigate the efficacy of JNJ-42165279 during 12 weeks of treatment in participants with Social Anxiety Disorder (SAD).

Detailed Study Description

This is a Phase 2a randomized (study drug assigned by chance), double-blind (neither the Investigator nor the participants know about the study intervention), placebo-controlled, parallel-group, multi-center study of JNJ-42165279 in participants with social anxiety disorder. Participants will receive 25 milligram (mg) JNJ-42165279 or matching placebo orally once-daily from Day 1 up to 12 weeks. Participants will primarily be assessed for the change from baseline in Liebowitz Social Anxiety Scale (LSAS) at Week 12. Safety will be monitored throughout the study.

Clinical Study Identifier: NCT02432703

Contact Investigators or Research Sites near you

Start Over

University of California at San ...

University of California at San Diego
La Jolla, CA United States
  Connect »

Hartford Hospital - Institute of ...

Hartford Hospital - Institute of Living
Hartford, CT United States
  Connect »

APG Research, LLC

APG Research, LLC
Orlando, FL United States
  Connect »

Rush University Medical Center

Rush University Medical Center
Chicago, IL United States
  Connect »

Massachusetts General

Massachusetts General
Boston, MA United States
  Connect »

Boston Center for Clinical Research, ...

Boston Center for Clinical Research, LLC
Natick, MA United States
  Connect »

Clinilabs

Clinilabs
New York, NY United States
  Connect »

The Medical Research Network, LLC

The Medical Research Network, LLC
New York, NY United States
  Connect »

Finger Lakes Clinical Research

Finger Lakes Clinical Research
Rochester, NY United States
  Connect »

Richmond Behavioural Associates

Richmond Behavioural Associates
Staten Island, NY United States
  Connect »

Lehigh Center for Clinical Research

Lehigh Center for Clinical Research
Allentown, PA United States
  Connect »

Berks Center for Clinical Research

Berks Center for Clinical Research
Reading, PA United States
  Connect »

Future Search Trials of Dallas

Future Search Trials of Dallas
Dallas, TX United States
  Connect »

PRA Health Sciences

PRA Health Sciences
Salt Lake City, UT United States
  Connect »

The Lyell McEwin Hospital

The Lyell McEwin Hospital
Adelaide, Australia
  Connect »

Peninsula Therapeutic & Research Group

Peninsula Therapeutic & Research Group
Frankston, Australia
  Connect »

Monash Alfred Psychiatry Research Centre

Monash Alfred Psychiatry Research Centre
Melbourne, Australia
  Connect »

The Melbourne Clinic

The Melbourne Clinic
Melbourne, Australia
  Connect »

Sir Charles Gairdner Hospital

Sir Charles Gairdner Hospital
Perth, Australia
  Connect »

Brain & Mind Research Institute

Brain & Mind Research Institute
Sydney, Australia
  Connect »

Chokka Center for Integrative Health

Chokka Center for Integrative Health
Edmonton, AB Canada
  Connect »

McMaster University

McMaster University
Hamilton, ON Canada
  Connect »

Nabil Philips - ON Canada

Nabil Philips - ON Canada
Mississauga, ON Canada
  Connect »

START Clinic for Mood and ...

START Clinic for Mood and Anxiety Disorders
Toronto, ON Canada
  Connect »

Centre for Addiction and Mental ...

Centre for Addiction and Mental Health
Toronto, ON Canada
  Connect »